M. Andoh

发表

A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer.

Y. Yatabe, K. Muro, T. Ura, 2016, Japanese journal of clinical oncology.

Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis

K. Muro, I. Oze, Y. Niwa, 2016, International Journal of Clinical Oncology.

Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma

I. Oze, Ken Kato, S. Iwasawa, 2020, International Journal of Clinical Oncology.

Weekly paclitaxel in patients with CAP-resistant advanced or recurrent endometrial carcinoma: a series of four patients

Y. Fujiwara, Toru Watanabe, N. Katsumata, 2005, International Journal of Clinical Oncology.

Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis

K. Muro, I. Oze, Y. Niwa, 2015, Cancer Chemotherapy and Pharmacology.

Adenocarcinoma of urachus. Report of 7 cases and review of literature.

T. Kakizoe, K. Matsumoto, Y. Nishio, 1983, Urology.

Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.

Y. Shiki, M. Yunokawa, T. Baba, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer.

K. Yonemori, C. Shimizu, Y. Fujiwara, 2006, Gynecologic oncology.

Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapy.

T. Shibata, C. Shimizu, T. Kinoshita, 2011, Human pathology.

A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer

K. Muro, D. Takahari, Kazuhisa Yamaguchi, 2015, BMC Cancer.

CA19-9 level as a prognostic and predictive factor of bevacizumab efficacy in metastatic colorectal cancer patients undergoing oxaliplatin-based chemotherapy

K. Muro, D. Takahari, Kazuhisa Yamaguchi, 2014, Cancer Chemotherapy and Pharmacology.

A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types

Susumu Hijioka, Masashi Andoh, Junichi Shimizu, 2019, International Journal of Clinical Oncology.

Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial

H. Iwata, H. Mukai, Y. Ohashi, 2014, Breast Cancer Research and Treatment.

A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer

K. Muro, D. Takahari, Kazuhisa Yamaguchi, 2015, BMC Cancer.

Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS.

K. Yonemori, C. Shimizu, Y. Fujiwara, 2009, Journal of proteome research.